Combining Advanced Therapies with Alternative Treatments: A New Approach to Managing Antimicrobial Resistance?
Greta Kaspute,
No information about this author
Arunas Zebrauskas,
No information about this author
Akvile Streckyte
No information about this author
et al.
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(5), P. 648 - 648
Published: May 15, 2025
Bacterial
antimicrobial
resistance
(AMR)
represents
a
critical
public
health
threat,
with
increasing
compromising
the
effectiveness
of
treatments
worldwide.
Resistance
trends,
such
as
fluctuating
benzylpenicillin
in
Staphylococcus
aureus,
highlight
growing
urgency,
projections
indicating
rise
to
various
antibiotics,
including
complete
gentamicin
and
tetracycline
by
2027.
Despite
substantial
efforts
develop
new
antibiotics
drug
delivery
systems,
these
approaches
must
undergo
rigorous
clinical
evaluation
ensure
their
safety
efficacy.
In
parallel,
alternative
therapies,
phytotherapy
apitherapy,
have
garnered
attention
for
potential
combating
infections.
Natural
substances
like
tea
tree
essential
oils
propolis,
which
exhibit
properties,
are
being
increasingly
incorporated
into
novel
systems.
However,
much
research
on
materials
is
not
new,
several
studies
already
exploring
effectiveness.
To
address
escalating
AMR
crisis,
combining
advanced
therapies
medicine
could
offer
promising
solution.
Advanced
therapy
products
target
bacterial
genomes
enhance
natural
substances.
This
integrated
approach
remains
underexplored
pre-clinical
trials,
presenting
future
opportunities
more
effective
strategies
AMR.
Given
rapid
spread
resistant
infections,
there
an
urgent
need
innovative
agents
overcome
emerging
mechanisms
improve
diagnoses
treatments.
Language: Английский
Exosomes Derived From Human Gingival Mesenchymal Stem Cells Induce Metabolic Reprogramming of Inflammatory Macrophages
Journal Of Clinical Periodontology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 19, 2025
ABSTRACT
Aim
To
investigate
the
influence
and
mechanism
of
exosomes
derived
from
human
gingival
mesenchymal
stem
cells
(GMSC‐Exo)
regulating
macrophage
polarisation
through
metabolic
reprogramming.
Materials
Methods
Human
acute
monocytic
leukaemia
(THP‐1)‐derived
macrophages
were
treated
with
GMSC‐Exo
or
Porphyromonas
gingivalis
lipopolysaccharide
(
P.g
‐LPS)
in
vitro.
Metabolic
inhibitors
used
to
study
role
reprogramming
GMSC‐Exo‐induced
polarisation,
while
hypoxia‐inducible
factor‐1
alpha
(HIF‐1α)
modulators
employed
explore
HIF‐1α
signalling
pathway's
impact
on
The
periodontitis
metabolism
was
assessed
using
a
rat
model
vivo.
Results
In
vitro
experiments
confirmed
that
promoted
pro‐inflammatory
M1
type
(classically
activated)
anti‐inflammatory
M2
(alternatively
by
promoting
(glycolysis
oxidative
phosphorylation).
this
process,
activation
pathway
inhibited.
vivo
revealed
could
regulate
inflammatory
microenvironment
periodontal
tissue
pattern
macrophages.
Conclusion
By
inhibiting
pathway,
trigger
macrophages,
thereby
transformation
phenotype
phenotype.
This
change
enhances
local
environment,
aiding
repair
regeneration.
Language: Английский